Bank of Montreal’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-68,435
Closed -$753K 4376
2023
Q2
$753K Sell
68,435
-168,311
-71% -$1.77M ﹤0.01% 2335
2023
Q1
$2.47M Hold
236,746
﹤0.01% 1596
2022
Q4
$2.43M Sell
236,746
-110,000
-32% -$1.12M ﹤0.01% 1696
2022
Q3
$3.48K Buy
346,746
+236,646
+215% +$2.37M ﹤0.01% 1543
2022
Q2
$1.09K Buy
+110,100
New +$1.09M ﹤0.01% 2248

Other funds holding BIOS

Bank of Montreal's BIOS Position: Q3 2023 in Review

Bank of Montreal sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q3 2023, closing a stake of 68,435 shares — an estimated $753K sold.

Bank of Montreal first reported a position in BIOS in Q2 2022 and held it in 5 quarters. The position peaked at $2.47M in Q1 2023. 30 funds tracked by Wall St. Rank hold BIOS as of Q3 2023.

  • Bank of Montreal reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 68,435 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q3 2023, an estimated $753K.
  • Bank of Montreal first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 5 quarters.
  • Bank of Montreal's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $2.47M in Q1 2023.
  • 30 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.